inVentiv Looks To Refi, Fund Deal

21 Jun 2007

inVentiv Health is tapping the loan market for an acquisition and refinancing.

inVentiv Health is tapping the loan market for an acquisition and refinancing. UBS and Bank of America lead the facility, which comprises a six-year, $50 million revolver; a seven-year, $330 million first-lien term loan and a seven-year, $20 million delayed-draw term loan. Pricing is LIBOR plus 1 3/4% ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.